samuel gonahasa - Infectious Diseases

Author Information

Samuel Gonahasa is affiliated with the Infectious Diseases Research Collaboration, located at 2C Nakasero Hill Road, Kampala, Uganda. His research primarily focuses on the study of malaria, including its incidence, prevention, and treatment strategies in Uganda. Gonahasa's work is significant in understanding malaria dynamics in East Africa, emphasizing the effectiveness and resistance of malaria treatment approaches.

Research Contributions

Samuel Gonahasa has made substantial contributions to the field of infectious diseases, with a particular emphasis on malaria research. His work includes evaluating the impact of long-lasting insecticidal nets (LLINs) both with and without piperonyl butoxide on malaria indicators, studying gender differences in malaria incidence, and assessing the effectiveness of vector control tools. Additionally, he has explored the efficacy and resistance associated with antimalarial drugs such as artemether-lumefantrine and dihydroartemisinin-piperaquine. His studies provide valuable insights into the challenges faced in controlling malaria, especially in regions like Uganda where the disease remains prevalent despite ongoing control measures.

Aliases

Samuel Gonahasa is also known by the alias Sam Gonahasa. This alias is sometimes used in academic publications and collaborations.

Publication and Citation Metrics

Metric	Value
Total Papers	33
Total Citations	486
H-index	13

Publications:

LLIN Evaluation in Uganda Project (LLINEUP) – Effect of Long-Lasting Insecticidal Nets with and Without Piperonyl Butoxide on Malaria Indicators in Uganda 25 Months after Distribution: A Cluster-Randomised Trial

DOI: 10.2139/ssrn.4081085

Year: 2022

Gender difference in the incidence of malaria diagnosed at public health facilities in Uganda

DOI: 10.1186/s12936-022-04046-4

Year: 2022

Optimising the deployment of vector control tools against malaria: a data-informed modelling study.

DOI: 10.1016/s2542-5196(21)00296-5

Year: 2022

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

DOI: 10.1186/s12936-022-04049-1

Year: 2022

Resurgence of malaria in Uganda despite sustained indoor residual spraying and repeated long lasting insecticidal net distributions

DOI: 10.1101/2022.02.18.22271193

Year: 2022

LLIN Evaluation in Uganda Project (LLINEUP) – The durability of long-lasting insecticidal nets treated with and without piperonyl butoxide (PBO) in Uganda

DOI: 10.1101/2022.02.17.480046

Year: 2022

The impact of stopping and starting indoor residual spraying on malaria burden in Uganda

DOI: 10.1038/s41467-021-22896-5

Year: 2021

Plasmodium falciparum parasite prevalence in East Africa: Updating data for malaria stratification

DOI: 10.1371/journal.pgph.0000014

Year: 2021

Gender Difference in the Incidence of Malaria Diagnosed at Public Health Facilities in Uganda

DOI: 10.21203/rs.3.rs-861110/v1

Year: 2021

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

DOI: 10.1186/s12936-021-04021-5

Year: 2021

What Challenges Exist in Implementing Personalized Medicine?

How Do X-rays Assist in Diagnosing Infections?

What Are Some of WHO’s Recent Initiatives in Infectious Disease Control?

What are Immunodeficiency Disorders?

How Can We Improve Vaccination Rates?

What Does the Future Hold for Personalized Medicine in Infectious Diseases?

How Long Can Respiratory Droplets Remain Infectious?

How do Pathogenic Microorganisms Cause Disease?

How is PCR Used in Epidemiological Studies?

What is the Treatment for Gonorrhea?

Partnered Content Networks

Relevant Topics